Dawes P T, Sheeran T P, Fowler P D, Shadforth M F
Clin Exp Rheumatol. 1987 Apr-Jun;5(2):151-3.
In a 6-month open pilot study 25 patients with Rheumatoid Arthritis (RA) whose disease was refractory to Gold or D-Penicillamine (DPA) were given Sulphasalazine (SAS) in addition. Three patients withdrew because of nausea. Twenty-two patients who completed therapy showed significant improvement in clinical and laboratory measures of disease activity.